Inclusion Criteria:  Patients from 5 years of age who are treated with TA Gräser top or TA Bäume top due to rhinitis, conjunctivitis and/or mild to moderate bronchial asthma, which are caused by an IgE-mediated allergy to grass and rye pollen or birch, alder and hazel pollen according to the respective SmPC. Patients will only be included in this study after the decision on the treatment has been made.  Exclusion Criteria:  History of allergen-specific immunotherapy (SIT) for trees or grass within the last 5 years If it´s intended to treat the patient with only a preseasonal therapy A patient should also not be included in the presence of any of the conditions listed in the respective SmPC